Building on GCAR’s experience developing and executing master protocol and platform trials, GCAR is working with a committed group of oncologists, statisticians, pathologists, neurosurgeons, imaging experts, advocates, and researchers from academia, industry, and government for all its collaborations and initiatives.
Brian M. Alexander, MD, MPH
Global Coalition for Adaptive Research
Valo Health
Flagship Pioneering
Derek C. Angus , MD, MPH, FRCP
UPMC and University of Pittsburgh School of Medicine
University of Pittsburgh
David Arons, JD
National Brain Tumor Society
Sujuan Ba, PhD
National Foundation for Cancer Research
Asian Fund for Cancer Research
AIM-HI Accelerator Fund
Donald A. Berry, PhD
The University of Texas MD Anderson Cancer Center
Berry Consultants
Scott Berry, MS, PhD
Berry Consultants
Nicholas A. Blondin, MD
Smilow Cancer Hospital and
Yale Comprehensive Cancer Center
Meredith Buxton, PhD, MPH
Global Coalition for Adaptive Research
Anthony Chalmers, MD, PhD
University of Glasgow
Tim Cloughesy, MD
Global Coalition for Adaptive Research
UCLA, Jonsson Comprehensive Cancer Center
David Geffen School of Medicine
Howard Colman, MD, PhD
Huntsman Cancer Institute
University of Utah
John de Groot, MD
UCSF Hellen Diller Family Comprehensive Cancer Center
University of California San Francisco
Macarena De la Fuente, MD
Sylvester Comprehensive Cancer Center
University of Miami Miller School of Medicine
Benjamin Ellingson, PhD
UCLA, Jonsson Comprehensive Cancer Center
David Geffen School of Medicine
Hui Gan, MBBS, PhD
Olivia Newton-John Cancer Research Institute
Austin Health
Andrew Giles
Cure Brain Cancer Foundation
Gary B. Gordon, MD, PhD
Global Coalition for Adaptive Research
David Huang, MD, MPH
University of Pittsburgh School of Medicine
Beth Y. Karlan, MD
UCLA, Jonsson Comprehensive Cancer Center
David Geffen School of Medicine
Mustafa Khasraw, MD
Duke Cancer Institute
Andrew B. Lassman, MD
Columbia University Vagelos College of Physicians and Surgeons
Herbert Irving Comprehensive Cancer Center
Eudocia Q. Lee, MD, MPH
Harvard Medical School
Dana-Farber Cancer Institute
Michael Lim, MD
Stanford University
Andrew W. Lo, PhD
MIT Sloan School of Management
Ursula A. Matulonis, MD
Dana-Farber Cancer Institute
Harvard Medical School
Florian B. Mayr, MD, MPH
University of Pittsburgh
Bryan J. McVerry, MD
University of Pittsburgh School of Medicine
Ingo K. Mellighoff, MD, FACP
Memorial Sloan Kettering Cancer Center
Tom Mikkelsen, MD
Henry Ford Cancer Institute
Robert F. Murray, III
Global Coalition for Adaptive Research
Kunle Odunsi, MD, PhD
University of Chicago Medicine
James Perry, MD, FRCPC
Sunnybrook Research Institute
University of Toronto
Tracey Roberts, BSN
Global Coalition for Adaptive Research
Lynda D. Roman, MD
Keck School of Medicine of USC
Christopher W. Seymour, MD, MSC
University of Pittsburgh
Anil K. Sood, MD
The University of Texas MD Anderson Cancer Center
Erik P. Sulman, MD, PhD
Duke University School of Medicine
Duke Cancer Center
Michael Weller, MD
University Hospital Zurich
Patrick Y. Wen, MD
Dana-Farber Cancer Institute
Harvard Medical School
W.K. Alfred Yung, MD
Global Coalition for Adaptive Research
The University of Texas MD Anderson Cancer Center